NCT07126171View on ClinicalTrials.gov

A Clinical Study on the Efficacy and Safety of Reduning Injection in the Treatment of Chikungunya Fever

NANot yet recruitingINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

August 28, 2025

Primary Completion Date

November 26, 2025

Study Completion Date

February 18, 2026

Conditions
Chikungunya Fever
Interventions
DRUG

Reduning injection

reduning Injection, intravenous drip, 20 ml per time, once a day;

DRUG

The simulant of Reduning Injection

The simulant of Reduning Injection, for intravenous drip, 20 ml per time, once a day

Trial Locations (1)

510080

The First Affiliated Hospital of Guangzhou Medical University, Guangzhou

Sponsors
All Listed Sponsors
lead

Jiangsu Kanion Pharmaceutical Co., Ltd

INDUSTRY

NCT07126171 - A Clinical Study on the Efficacy and Safety of Reduning Injection in the Treatment of Chikungunya Fever | Biotech Hunter | Biotech Hunter